BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37768037)

  • 1. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
    Semenza GL
    Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.
    Yang Y; Chen C; Zuo Q; Lu H; Salman S; Lyu Y; Huang TY; Wicks EE; Jackson W; Datan E; Wang R; Wang Y; Le N; Zhu Y; Qin W; Semenza GL
    Sci Adv; 2022 Dec; 8(49):eabo5000. PubMed ID: 36490339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.
    Lu H; Lyu Y; Tran L; Lan J; Xie Y; Yang Y; Murugan NL; Wang YJ; Semenza GL
    Cell Rep; 2021 Sep; 36(13):109757. PubMed ID: 34592152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
    Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
    J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
    Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
    Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis.
    Zuo Q; Yang Y; Lyu Y; Yang C; Chen C; Salman S; Huang TY; Wicks EE; Jackson W; Datan E; Qin W; Semenza GL
    Cell Rep; 2023 Mar; 42(3):112164. PubMed ID: 36857181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
    Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
    Lan J; Lu H; Samanta D; Salman S; Lu Y; Semenza GL
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9640-E9648. PubMed ID: 30242135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
    Xiang L; Semenza GL
    Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
    Luo W; Chang R; Zhong J; Pandey A; Semenza GL
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):E3367-76. PubMed ID: 23129632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.
    Xiang L; Gilkes DM; Hu H; Takano N; Luo W; Lu H; Bullen JW; Samanta D; Liang H; Semenza GL
    Oncotarget; 2014 Dec; 5(24):12509-27. PubMed ID: 25587023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
    Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
    Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF induces human embryonic stem cell markers in cancer cells.
    Mathieu J; Zhang Z; Zhou W; Wang AJ; Heddleston JM; Pinna CM; Hubaud A; Stadler B; Choi M; Bar M; Tewari M; Liu A; Vessella R; Rostomily R; Born D; Horwitz M; Ware C; Blau CA; Cleary MA; Rich JN; Ruohola-Baker H
    Cancer Res; 2011 Jul; 71(13):4640-52. PubMed ID: 21712410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.